a School of Pharmacy, Department of Pharmacy Practice , Monash University Malaysia, Bandar Sunway , Selangor , Malaysia.
b Center of Pharmaceutical Outcomes Research (CPOR) , Department of Pharmacy Practice.
Hum Vaccin Immunother. 2018 Jan 2;14(1):124-133. doi: 10.1080/21645515.2017.1381811. Epub 2017 Nov 17.
A scoping review was performed to identify factors that may lead to human papillomavirus (HPV) vaccine hesitancy among women in low- and middle-income countries in South East Asian Region (SEAR) and Western Pacific Region (WPR). A systematic search of English and non-English articles using Pubmed, EMBASE, PsycINFO, Cochrane, MEDLINE, and CINAHL plus was conducted. Only 63 studies conducted in SEAR and WPR were included from inception until December 2016. Results of these studies have shown that poor awareness and knowledge of practices on cervical cancer prevention was evident in both SEAR and WPR. Concerns on safety and efficacy of the vaccine, and costs in getting vaccinated were significant barriers. Most women stated that they needed more information, and strongly welcomed a physician's recommendation in both geographical regions. Women also felt they have a low risk of acquiring HPV infection and cervical cancer. Most women in SEAR and WPR were unable to decide on whether to accept HPV vaccination.
本研究旨在明确东南亚地区(SEAR)和西太平洋地区(WPR)低收入和中等收入国家女性对人乳头瘤病毒(HPV)疫苗犹豫不决的原因。通过使用 Pubmed、EMBASE、PsycINFO、Cochrane、MEDLINE 和 CINAHL plus 对英文和非英文文献进行了系统检索。纳入的研究仅为 2016 年 12 月前 SEAR 和 WPR 地区开展的研究,结果表明,这两个地区的女性对宫颈癌预防措施的认识和了解都很差。对疫苗安全性和有效性的担忧以及接种疫苗的费用是显著的障碍。大多数女性表示她们需要更多的信息,并在这两个地区都非常欢迎医生的推荐。女性也认为她们感染 HPV 和宫颈癌的风险较低。SEAR 和 WPR 的大多数女性无法决定是否接受 HPV 疫苗接种。